The revenue decline and loss of the Tissue contracts are over and fully priced into the current pps.
No one will deny that hurt, but having Red Oak here managing CBAI through it was huge.
Check the share count, no dilution now for well over a year. Tonaquint Note will be paid off in a matter of months, recurring rev on the Cord side is increasing.
Replacing the old management here with responsible shareholder friendly management will prove to be exactly what this co needed.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.